94-20-2 Usage
Description
Chlorpropamide, also known as 4-chloro-N-[(propylamino)carbonyl]benzenesulfonamide or 1-[(p-chlorophenyl)sulfonyl]-3-propylurea, is a long-acting sulfonylurea derivative and hypoglycemic agent. It is a white crystalline powder with a slight odor, practically insoluble in water, soluble in alcohol, and sparingly soluble in chloroform. Chlorpropamide is used in the treatment of type 2 diabetes mellitus, particularly when dietary modifications are not sufficient to control blood sugar levels. It acts by increasing insulin secretion and is ineffective in patients without functional pancreatic beta cells.
Uses
Used in Pharmaceutical Industry:
Chlorpropamide is used as an oral hypoglycemic agent for the treatment of type 2 diabetes mellitus. It is effective in managing blood sugar levels in patients who do not respond to dietary modifications alone.
Used in Diabetes Management:
Chlorpropamide is used as a long-acting medication to control high blood sugar levels in patients with type 2 diabetes. It helps increase insulin secretion, thereby reducing blood glucose levels and managing the disease effectively.
Brand Names:
Diabinese (Pfizer) and Glucamide (Teva) are some of the brand names under which Chlorpropamide is marketed.
Originator
Diabinese ,Pfizer, US,1958
Manufacturing Process
A solution of 54 g (0.64 mol) of propyl isocyanate in 60 ml of anhydrousdimethylformamide was added to a cold, well-stirred suspension of 81 g (0.42
mol) of dry p-chlorobenzenesulfonamide in 210 ml of anhydrous triethylamine
during the course of 20 to 30 minutes. The mildly exothermic reaction was
completed by allowing it to stand at room temperature for about 5 hours. The
reaction mixture was then slowly added to 3 liters of cold 20% acetic acid
during the course of about one hour, constant agitation being maintained
throughout the addition.
After the addition was complete, the desired product, which had crystallized
out, was filtered and washed well with about 2 liters of cold water. The crude
material was then dissolved in 1 liter of cold 5% sodium carbonate and the
resulting solution was immediately filtered from an insoluble gum. The product
was then reprecipitated, by slowly adding the filtrate to 3 liters of 20% acetic
acid. The precipitate, which is very nearly pure N-(p-chlorobenzenesulfonyl)-
N'-propylurea, was then dried and subsequently recrystallized from about 800
ml of benzene to give a 59% yield of pure product, MP 129.2 to 129.8°C.
Air & Water Reactions
Insoluble in water.
Fire Hazard
Flash point data for CHLORPROPAMIDE are not available; however, CHLORPROPAMIDE is probably combustible.
Veterinary Drugs and Treatments
While chlorpropamide could potentially be of benefit in the adjunctive
treatment of diabetes mellitus in small animals, its use has been
primarily for adjunctive therapy in diabetes insipidus in dogs and
cats.
Purification Methods
Crystallise the urea from aqueous EtOH. [Beilstein 11 IV 119.]
Check Digit Verification of cas no
The CAS Registry Mumber 94-20-2 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 9 and 4 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 94-20:
(4*9)+(3*4)+(2*2)+(1*0)=52
52 % 10 = 2
So 94-20-2 is a valid CAS Registry Number.
InChI:InChI=1/C10H13ClN2O3S/c1-2-7-12-10(14)13-17(15,16)9-5-3-8(11)4-6-9/h3-6H,2,7H2,1H3,(H2,12,13,14)
94-20-2Relevant articles and documents
Rapid Multigram-Scale End-to-End Continuous-Flow Synthesis of Sulfonylurea Antidiabetes Drugs: Gliclazide, Chlorpropamide, and Tolbutamide
Sagandira, Cloudius R.,Watts, Paul
supporting information, (2021/12/02)
A multigram-scale robust, efficient, and safe end-to-end continuous-flow process for the diabetes sulfonylurea drugs gliclazide, chlorpropamide, and tolbutamide is reported. The drugs were prepared by the treatment of an amine with a haloformate affording carbamate, which was subsequently treated with a sulfonamide to afford sulfonylurea. Gliclazide was obtained in 87% yield within 2.5 minutes total residence time with 26 g/h throughput; 0.2 kg of the drug was produced in 8 hours of running the system continuously. Chlorpropamide and tolbutamide were both obtained in 94% yield within 1 minute residence time with 184-188 g/h throughput; 1.4-1.5 kg of the drugs was produced in 8 hours of running the system continuously. N-Substituted carbamates were used as safe alternatives to the hazardous isocyanates in constructing the sulfonyl urea moiety.
Mechanosynthesis of pharmaceutically relevant sulfonyl-(thio)ureas
Tan, Davin,?trukil, Vjekoslav,Mottillo, Cristina,Fri??i?, Tomislav
supporting information, p. 5248 - 5250 (2014/05/06)
We demonstrate the first application of mechanochemistry to conduct the synthesis of sulfonyl-(thio)ureas, including known anti-diabetic drugs tolbutamide, chlorpropamide and glibenclamide, in good to excellent isolated yields by either stoichiometric base-assisted or copper-catalysed coupling of sulfonamides and iso(thio)cyanates. the Partner Organisations 2014.
Lewis Acid Catalysed Preparation of some Carbamates and Sulphonylureas. Application to the Determination of Enantiomeric Purity of Chiral Alcohols
Irie, Hiroshi,Nishimura, Masataka,Yoshida, Morihiro,Ibuka, Toshiro
, p. 1209 - 1210 (2007/10/02)
Lewis acids such as boron trifluoride-diethyl ether and aluminium chloride catalyze the reaction of alcohols and sulphonamides with isocyanates, affording carbamates and sulphonylureas, respectively, in acceptable yield.Applied to the formation of diastereoisomeric carbamates from chiral alcohols using Pirkle's reagents, , this technique provides a convenient method for determination of enantiomeric purity.